Stock jumped 5% in one day, way ahead of FMCG peers. From a low of ₹216 last year, that's over 60% up – beats the Sensex hands down. Feels like momentum's kicking in, right? But is it a flash or here to stay?
Key Numbers at a Glance:
Market cap sits around ₹9,700 crore, with shares near ₹300 lately. P/E ratio? A hefty 62-70x, compared to FMCG industry average of 33-38x – pricey, man. No dividends yet, yield at 0%, since they're plowing cash back in.
Debt? Almost zero – super clean balance sheet, debt-to-equity negative even, meaning they're cash rich. ROE around 5-6%, ROCE 7%, not screaming but steady. Profit growth? Q3 FY26 net profit exploded 93% YoY to ₹50 crore, though full FY25 was mixed with sales up 5-6% but profits down 47% earlier due to marketing spends. Cash flow positive lately, ₹78 crore operating in FY25.
Varun Alagh and Ghazal Alagh started it in 2016. New parents, couldn't find toxin-free baby stuff – boom, Mamaearth born. Went public in 2023, now India's top digital-first beauty player. Varun's the CEO, hustling hard. Kinda like that friend who turned a home problem into a billion-rupee biz.
What They Do:
House of brands: Mamaearth (natural baby/skin), The Derma Co (science skincare), Aqualogica (hydration), BBlunt (hair), Dr. Sheth's, more. Digital-first, now in 750 districts, omni-channel. Target millennials craving clean, techy beauty – no parabens, think safe for your kid's soft skin. Business model? Direct-to-consumer online, influencers, expand offline. Smart, scalable.
What's Next?
Price Guesses
Short term, riding this breakout – could test ₹350 soon if profits keep surging. For 2026, analysts say ₹285-320, assuming margins hit 15%. By 2030, maybe ₹345-460 if sales grow 20% yearly.
Longer? Wild cards. 2035 around ₹5,000-6,000? 2040 even ₹10,000-15,000? Optimistic forecasts banking on D2C boom, but c'mon, that's moonshot – needs flawless execution. Risks? Competition from HUL, high P/E could bite if growth slows.
No comments:
Post a Comment
Blog kaisa laga, please likh kar bataye ♥️